Skip to content
★ Sign in to follow
KJ

Kenneth J. Hillan

Board Director
Director
23andMe Holding Co.Sangamo Therapeutics, IncAchaogen, Inc.Relypsa Inc
Total declarations
34
Companies
4
▲ Purchases (0 ops.)
—
▼ Sales (9 ops.)
€267k

Latest filing published 16 Jun 2025 for Sangamo Therapeutics, INC.

Filing timeline

BuySale
Kenneth J. Hillan

Insider track record

Disclosed buys
0
Disclosed sells
9
Signal history

Kenneth J. Hillan: trading record in brief

Kenneth J. Hillan, listed as board member, has filed trades across 4 companies (mainly through SEC (Form 4)), most often in Achaogen, Inc., 23andMe Holding Co. and Sangamo Therapeutics, Inc. Between 11 March 2015 and 12 June 2025, the trades on record add up to 34 filings.

No open-market purchase appears, only 9 sales worth €267k. Other entries cover 21 share grants and 2 option exercises.

On 16 June 2025 came the latest disclosure, a share grant in Sangamo Therapeutics, Inc. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.

Companies and markets linked to Kenneth J. Hillan

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations34 total

25 of 34 declarations